## RJF: Raymond James Financial, Inc. - XLF: Financial Services

### Executive Summary

No thesis match: MRS_10 -0.4% below STRENGTH zone (3.0-6.0%); PEG 1.23 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($159.22)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 1, Bearish: 0)

**1. Voya Investment Management LLC Trims Stock Position in Raymond James Financial, Inc. $RJF**
- Source: MarketBeat | 20251225T132828 | Neutral | Relevance: 100%
- Voya Investment Management LLC has reduced its stake in Raymond James Financial, Inc. (NYSE:RJF) by 23.9%, selling 12,362 shares and ending with 39,470 shares valued at $6.81 million. Despite this, Raymond James Financial exceeded Q3 earnings estimates with $3.11 EPS and $3.73 billion in revenue, also raising its quarterly dividend to $0.54. Institutional investors hold a significant 83.8% of the company's stock, though insider Paul C. Reilly recently sold a substantial portion of his holdings.

**2. GPs starting to stomach discounts on lower-tier assets, says Raymond Jamesâ€™ Sunaina Sinha Haldea; Stonepeak agrees to Castrol deal**
- Source: PE Hub | 20251224T050856 | Neutral | Relevance: 100%
- The article discusses the private equity landscape at the end of 2025, noting that dealmaking, while up from previous years, did not meet initial high expectations. Sunaina Sinha Haldea of Raymond James suggests that General Partners are becoming more accepting of discounts on lower-tier assets, and Stonepeak has agreed to acquire a majority stake in Castrol. The piece offers a brief overview of the year's private equity trends.

**3. Raymond James Financial, Inc. (NYSE:RJF) Receives Consensus Recommendation of "Hold" from Analysts**
- Source: MarketBeat | 20251225T061856 | Neutral | Relevance: 96%
- Raymond James Financial, Inc. (NYSE:RJF) has received a consensus "Hold" rating from thirteen analysts, with an average one-year price target of $180.73. Insider activity included Director Paul C. Reilly selling a significant portion of his shares, while institutional investors like Primecap Management Co. CA and JPMorgan Chase & Co. increased their holdings. The company also announced an increase in its quarterly dividend to $0.54 per share.

**4. Raymond James downgrades KB Home on disappointing Q4 results, near-term risks**
- Source: Investing.com | 20251224T091856 | Somewhat-Bearish | Relevance: 81%
- Raymond James has downgraded KB Home (NYSE: KBH) to Market Perform from Outperform following the homebuilder's "disappointing" fourth-quarter results and concerns over its shift to a build-to-order model. Analyst Buck Horne highlighted weaker-than-expected earnings, higher impairments, and reduced backlog average selling prices as key factors, suggesting that a return to normalized gross margins could be delayed until fiscal 2027 or later. The change in strategy is seen as a potential tactical disadvantage in the current affordability-driven market.

**5. Invesco BulletShares 2031 Corporate Bond ETF $BSCV Shares Purchased by Everpar Advisors LLC**
- Source: Defense World | 20251228T100943 | Somewhat-Bullish | Relevance: 74%
- Everpar Advisors LLC significantly increased its stake in Invesco BulletShares 2031 Corporate Bond ETF (NASDAQ:BSCV) by 125.4% during the third quarter, owning 68,571 shares worth $1,144,000. Several other institutional investors also adjusted their holdings in BSCV, which recently announced a monthly dividend and trades with a 50-day moving average of $16.70. The ETF invests in investment-grade corporate bonds with effective maturities in 2031.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 2, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-22 | Morgan Stanley | $187 | $185 | +1% |
| 2025-12-10 | B of A Securiti | $196 | $194 | +1% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-22 | Morgan Stanley | main | Equal-Weight |
| 2025-12-10 | B of A Securiti | main | Neutral |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 31 ($0.00M) |
| Sells | 18 ($0.53M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 46.6% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 1 / 9 |

**Top Holders:**
- Vanguard Group Inc: 11.1% (-1.4%)
- Blackrock Inc.: 7.4% (-2.9%)
- JPMORGAN CHASE & CO: 5.9% (+108.2%)
- Primecap Management : 4.9% (-3.7%)
- Wellington Managemen: 4.6% (-5.8%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.23 suggests fair value with growth premium. Forward P/E 12.3x attractive for 12% earnings growth. Quality metrics strong (margin 15%). Institutional flow bullish (1 buying vs 9 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $33.0B |
| Beta | 1.01 |
| 52W Range | $117.57 - $177.66 |
| Short Interest | 4.3% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.23 |
| Forward P/E | 12.3 |
| Current P/E | 13.8 |
| YoY Growth | 12.4% |
| EPS Direction | STABLE |

### Technicals

MRS_10 stable at -0.4% (minimal 5-day change). Below STRENGTH zone by 3.4pp (needs >3.0% for momentum thesis). Full SMA alignment bullish (above 20/50/200 SMAs). RSI neutral at 58. OFD pattern: -SUL (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -0.39% (CS: 64) | Neutral |
| RSI_14 | 58.5 | Neutral |
| MACD Histogram | 0.39 | Bullish |
| vs SMA20 | 1.018x | Above |
| vs SMA50 | 1.028x | Above |
| vs SMA200 | 1.060x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $165.30
- **Stop Loss:** $159.22 (3.7% risk)
- **Target:** $171.38 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 217
- **Position Value:** $35,870.10
- **Portfolio %:** 35.87%
- **Risk Dollars:** $1,320.00
- **Risk Per Trade:** 1.32%
- **Modifiers:** L1 110% | L2 120% | Combined 1.32x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.10x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with selective risk appetite amid holiday trading. VIX at extreme lows (13.6) signals complacency while positive yield curve (+59bps) and stable economic data support continuation. Focus on quality names with AI/infrastructure exposure while monitoring January volatility reset.*

### Earnings

**Next:** 2026-01-28 (Est: $2.93)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.83 | $3.11 | +10.0% |
| 2025Q2 | $2.36 | $2.18 | -7.5% |
| 2025Q1 | $2.44 | $2.42 | -0.7% |
| 2024Q4 | $2.69 | $2.93 | +8.8% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_10*